Do motor-nerve terminals have gamma-aminobutyric acid receptors?
- PMID: 6258690
- PMCID: PMC2044428
- DOI: 10.1111/j.1476-5381.1980.tb10937.x
Do motor-nerve terminals have gamma-aminobutyric acid receptors?
Abstract
1 gamma-Aminobutyric acid (GABA, 0.1 to 1 mM) had no significant effect on the amplitude, rise time, half decay time or frequency of miniature endplate potentials (m.e.p.ps) at the frog or mouse neuromuscular junctions in vitro. 2 Addition of GABA (1 mM) to preparations previously treated with 11 mM K+-Ringer did not cause any further increase in m.e.pp. frequency. GABA also failed to increase the m.e.p.p. frequency in a low Cl--Ringer. 3 GABA (0.1 to 1 mM) did not reduce the high m.e.p.p. frequency induced by veratrine (20 to 40 mg/l). 4 GABA (0.5 to 1 mM) did not affect the amplitude of the extracellularly-recorded nerve terminal spike, whereas 15 mM [K+] reduced the spike. 5 The quantal content (m) of the evoked endplate potential was not significantly altered by GABA; 9 mM [K+] significantly increased m. 6 When external d.c. potential differences were recorded in a three-chambered bath, GABA (0.1 to 1 mM) produced a very small depolarization if applied to the phrenic nerve trunk, but not if applied to the pre-terminal axon/motor nerve terminal region. Carbachol (0.3 to 1 mM) evoked a small depolarization when applied to the nerve terminal chamber. 7 These results fail to provide evidence for the existence of GABA receptors on motor nerve terminals.
Similar articles
-
Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.Br J Pharmacol. 1991 Sep;104(1):133-8. doi: 10.1111/j.1476-5381.1991.tb12397.x. Br J Pharmacol. 1991. PMID: 1686201 Free PMC article.
-
Ciguatoxin enhances quantal transmitter release from frog motor nerve terminals.Br J Pharmacol. 1990 Apr;99(4):695-700. doi: 10.1111/j.1476-5381.1990.tb12991.x. Br J Pharmacol. 1990. PMID: 1972891 Free PMC article.
-
Effects of the potassium channel blocking dendrotoxins on acetylcholine release and motor nerve terminal activity.Br J Pharmacol. 1988 Jan;93(1):215-21. doi: 10.1111/j.1476-5381.1988.tb11424.x. Br J Pharmacol. 1988. PMID: 2450611 Free PMC article.
-
4-Aminopyridine and evoked transmitter release from motor nerve endings.Br J Pharmacol. 1978 Dec;64(4):623-9. doi: 10.1111/j.1476-5381.1978.tb17325.x. Br J Pharmacol. 1978. PMID: 31961 Free PMC article.
-
GABA potentiates the depolarization-induced release of glutamate from cerebellar nerve endings.Adv Biochem Psychopharmacol. 1981;27:127-37. Adv Biochem Psychopharmacol. 1981. PMID: 6108691 Review. No abstract available.
Cited by
-
Actions of agonists, fipronil and ivermectin on the predominant in vivo splice and edit variant (RDLbd, I/V) of the Drosophila GABA receptor expressed in Xenopus laevis oocytes.PLoS One. 2014 May 13;9(5):e97468. doi: 10.1371/journal.pone.0097468. eCollection 2014. PLoS One. 2014. PMID: 24823815 Free PMC article.
-
Immunohistochemical evidence of the presence of metabotropic receptors for γ-aminobutyric acid at the rat neuromuscular junctions.Dokl Biochem Biophys. 2015;463:236-8. doi: 10.1134/S1607672915040092. Epub 2015 Sep 3. Dokl Biochem Biophys. 2015. PMID: 26335820
-
The differential effects of baclofen on segmental and descending excitation of spinal interneurones in the cat.Exp Brain Res. 1985;58(2):333-7. doi: 10.1007/BF00235314. Exp Brain Res. 1985. PMID: 2987015
-
The inhibitory amino acid GABA hyperpolarizes motor axons: an intracellular study.Experientia. 1983 Feb 15;39(2):225-8. doi: 10.1007/BF01958914. Experientia. 1983. PMID: 6299776 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous